Equities research analysts predict that HCA Healthcare Inc (NYSE:HCA) will announce earnings per share (EPS) of $2.14 for the current fiscal quarter, according to Zacks Investment Research. Ten analysts have issued estimates for HCA Healthcare’s earnings, with the highest EPS estimate coming in at $2.31 and the lowest estimate coming in at $2.03. HCA Healthcare reported earnings per share of $2.16 during the same quarter last year, which would suggest a negative year-over-year growth rate of 0.9%. The company is scheduled to report its next earnings results on Tuesday, October 29th.
According to Zacks, analysts expect that HCA Healthcare will report full-year earnings of $10.40 per share for the current fiscal year, with EPS estimates ranging from $10.27 to $10.50. For the next year, analysts expect that the business will report earnings of $11.27 per share, with EPS estimates ranging from $10.83 to $11.50. Zacks’ earnings per share averages are a mean average based on a survey of research firms that that provide coverage for HCA Healthcare.
HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $2.21 earnings per share for the quarter, missing analysts’ consensus estimates of $2.49 by ($0.28). HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The firm had revenue of $12.60 billion during the quarter, compared to analysts’ expectations of $12.61 billion. During the same quarter in the previous year, the firm earned $2.29 earnings per share. HCA Healthcare’s revenue was up 9.3% on a year-over-year basis.
A number of brokerages have weighed in on HCA. Deutsche Bank boosted their target price on shares of HCA Healthcare from $160.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Goldman Sachs Group upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating and boosted their target price for the company from $147.00 to $160.00 in a research note on Wednesday, July 10th. UBS Group boosted their target price on shares of HCA Healthcare from $172.00 to $181.00 and gave the company a “buy” rating in a research note on Monday, June 24th. Zacks Investment Research lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 target price for the company. in a research note on Monday, May 27th. Finally, Mizuho set a $153.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, July 31st. Two analysts have rated the stock with a sell rating, two have issued a hold rating and seventeen have issued a buy rating to the stock. HCA Healthcare currently has an average rating of “Buy” and a consensus price target of $153.35.
In other news, SVP Kathleen M. Whalen sold 977 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $127.56, for a total transaction of $124,626.12. Following the transaction, the senior vice president now directly owns 11,484 shares of the company’s stock, valued at $1,464,899.04. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Robert A. Waterman sold 33,786 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $134.98, for a total transaction of $4,560,434.28. Following the transaction, the senior vice president now directly owns 279,551 shares in the company, valued at $37,733,793.98. The disclosure for this sale can be found here. Corporate insiders own 2.70% of the company’s stock.
Several large investors have recently modified their holdings of the company. Westside Investment Management Inc. bought a new position in shares of HCA Healthcare during the second quarter valued at approximately $34,000. Doyle Wealth Management bought a new position in shares of HCA Healthcare during the second quarter valued at approximately $34,000. NEXT Financial Group Inc bought a new position in shares of HCA Healthcare during the second quarter valued at approximately $43,000. Financial Gravity Wealth Inc. bought a new position in shares of HCA Healthcare during the first quarter valued at approximately $47,000. Finally, Valeo Financial Advisors LLC bought a new position in shares of HCA Healthcare during the first quarter valued at approximately $66,000. 70.23% of the stock is currently owned by institutional investors and hedge funds.
NYSE HCA traded up $0.66 during mid-day trading on Monday, reaching $123.93. The stock had a trading volume of 1,444,200 shares, compared to its average volume of 1,941,547. HCA Healthcare has a 1 year low of $110.31 and a 1 year high of $147.42. The stock has a market cap of $42.03 billion, a PE ratio of 12.68, a price-to-earnings-growth ratio of 1.06 and a beta of 0.85. The company has a fifty day moving average price of $135.04 and a 200 day moving average price of $131.44.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Tuesday, September 3rd will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date of this dividend is Friday, August 30th. HCA Healthcare’s dividend payout ratio (DPR) is currently 16.38%.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Further Reading: What are the benefits of momentum investing?
Get a free copy of the Zacks research report on HCA Healthcare (HCA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.